Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
- 1 February 2014
- journal article
- review article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 67, 353-365
- https://doi.org/10.1016/j.freeradbiomed.2013.10.819
Abstract
No abstract availableFunding Information
- Global Core Research Center (2011–0030676 to Y.-J. Surh)
- Basic Science Research Program (2009–0077736 to H.-K. Na)
- National Research Foundation
This publication has 138 references indexed in Scilit:
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 SignalingCancer Cell, 2011
- Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancerCancer Chemotherapy and Pharmacology, 2011
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisNature, 2011
- INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosisCell Death & Differentiation, 2010
- Antioxidant-induced Phosphorylation of Tyrosine 486 Leads to Rapid Nuclear Export of Bach1 That Allows Nrf2 to Bind to the Antioxidant Response Element and Activate Defensive Gene ExpressionPublished by Elsevier BV ,2010
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesisBritish Journal of Cancer, 2008
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences of the United States of America, 2008
- Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosisBiochemical Pharmacology, 2008
- Mdm2 promotes the rapid degradation of p53Nature, 1997